Iray Imaging Technology (Haining) Limited · Class II · Cleared Mar 18, 2025
| K-number | K243556 |
| Device name | Lux HD 35 Detector (Lux HD 35); Lux HD 43 Detector (Lux HD 43) |
| Applicant | Iray Imaging Technology (Haining) Limited |
| Product code | MQB |
| Device class | Class II |
| Decision date | Mar 18, 2025 |
| Decision | Substantially Equivalent |
| Regulation | 892.1680 |
The Lux HD 35 and Lux HD 43 Detectors are digital flat-panel X-ray imaging devices designed to convert X-rays to digital images for general radiographic diagnosis in both adult and pediatric patients. They replace traditional film/screen systems in general-purpose diagnostic procedures but are not intended for mammography or dental applications.
Both models use a TFT/photodiode array with CsI scintillator, 100 μm pixel size, and 16-bit ADC digitization. The Lux HD 35 has a 350×430 mm active area (3500×4300 pixels) while the Lux HD 43 has a 426.7×426.7 mm active area (4267×4267 pixels). Both achieve 5.0 lp/mm spatial resolution and 0.54 DQE at 1 lp/mm. They support wireless or wired operation, with improved IP67 rating and enhanced local load tolerance (150 kg) compared to the predicate device.
IEC/ES 60601-1 for electrical, mechanical, and environmental safety; IEC 60601-1-2 for EMC testing; ANSI IEEE C63.27-2017 for wireless functionality and coexistence; FDA guidance on solid-state X-ray imaging devices and cybersecurity in medical devices.
The proposed devices share identical intended use, fundamental technology, and regulatory classification with the Focus HD 43 predicate (K213529). Non-clinical performance (spatial resolution, DQE, safety, EMC) is substantially equivalent. Clinical considerations remain the same, with no negative changes in imaging performance. The Lux HD 35 represents a size variation using the same technology platform, while the Lux HD 43 matches the predicate's footprint with minor enhancements (IP rating, structural robustness) that do not alter safety or effectiveness.
View the full FDA submission: accessdata.fda.gov